А. А. Попова
Russian Medical Academy of Continuous Professional Education · 20 works · 29 citations · h-index 3
Top works
- Prevalence of high oncogenic risk genotypes of human papillomavirus in HIV-positive and HIV-negative females
- A clinical case of three times treatment of hepatitis C with repeated infection in HIV-positive patient. Case Report
- Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study
- Comparison of efficacy and safety of antiretroviral first-line therapy with phosphazideortdf
- Genetic polymorphism associated with cervical cancer: a systematic review
- Clinical significance of the UGT1A1*28 allele detection in HIV‐infected patients
- [The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection].
- The duration of an HIV infection course and its influencing factors
- Prevalence of human papillomavirus (Papillomaviridae; Human papillomavirus) of high carcinogenic risk based on the results of screening of three anatomical loci in men stratified by sexual behavior and HIV status
- ГЕНЕТИЧЕСКИЕ МАРКЕРЫ КЛИНИЧЕСКИ ВЫРАЖЕННЫХ НЕЖЕЛАТЕЛЬНЫХ ЯВЛЕНИЙ У БОЛЬНЫХ С ВИЧ-ИНФЕКЦИЕЙ, ПОЛУЧАЮЩИХ АНТИРЕТРОВИРУСНУЮ ТЕРАПИЮ
- Продолжительность течения ВИЧ-инфекции и влияющие на нее факторы
- Эффективность и безопасность схемы терапии, включающей ралтегравир и комбинированный препарат с фиксированными дозами ламивудина и абакавира, у пациентов с туберкулезом и ВИЧ-инфекцией, получавших рифабутин
- COMPARATIVE STUDY OF “KLIM-TEST” MONOCLONAL ANTIBODIES FOR PHENOTYPING OF PERIPHERAL BLOOD CELLS WITH MONOCLONALS FROM FOREIGN PRODUCERS
- СРАВНЕНИЕ ЭФФЕКТИВНОСТИ И БЕЗОПАСНОСТИ СХЕМ АНТИРЕТРОВИРУСНОЙ ТЕРАПИИ ПЕРВОЙ ЛИНИИ, ВКЛЮЧАВШИХ ФОСФАЗИД ИЛИ ТЕНОФОВИР
- Prevalence of Betapolyomavirus hominis in people at risk of developing infectious complications associated with virus reactivation
- Analysis of HIV-1 genetic variants and drug resistance among men with high-risk sexual behavior, Cuban citizens, living in Moscow in 2022–2024
- Awareness of Women with Different HIV Status about Papillomavirus Infection in Some Countries of Eastern Europe and Central Asia
- Human papillomavirus of high carcinogenic risk in HIV-infected women in Eastern Europe and Central Asia
- Changes in HIV‑1 genetic diversity among men who have sex with men living in Russia in the period 2004–2025
- The influence of genetic factors on the effectiveness, safety and tolerability of antiretroviral therapy in patients with hiv infection